TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation. April 14, 2006
TCL Archive In Brief: san Antonio’s ICRC Gets a New Name, SACI; Blum Is deputy Oncology Director At Kaplan May 14, 1993
